3rd Quarter - Report

QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitor implementation of H.R. 1865, Further Consolidated Appropriations Act, 2020, (Public Law 116-94) and provisions related to policies regarding data collection from laboratories under the Protecting Access to Medicare Act (PAMA).

LobbyistCovered position, as disclosed
ISHAN SHAH New —
SHERRY HARPER WIDICUS —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 1865 (117th)

Health Issues HCR

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Laboratory Developed Test (LDT) reform pathway engagement. H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19. H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. Tracking COVID-19 Variants Act (H.R. 791, S. 236), legislation to support genomic surveillance and expand sequencing of SARS-CoV-2. Issues related to the implementation of surprise billing law related to laboratory treatments. Federal policy and programs related to K-12 schools testing for COVID-19. Federal policy and programs ensuring an equitable pandemic response and recovery.

LobbyistCovered position, as disclosed
ISHAN SHAH New —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP)

Bills named: H.R. 6201 (117th), S. 236 (117th), H.R. 133 (117th), H.R. 1319 (117th), H.R. 791 (117th), H.R. 748 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.